Gaucher Disease Enzyme Activity in Leukocytes
Synonyms |
|
||||||||||||
Cerner Name |
|||||||||||||
Clinical Info |
Use to diagnose Gaucher disease only; not indicated for carrier screening. |
||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||
Specimen Types |
Blood |
||||||||||||
Specimen Volume |
|||||||||||||
Container |
Lavender Top Tube |
||||||||||||
Collection Instructions |
Container/Tube: Lavender EDTA Top Tube or Yellow ACD Tube |
||||||||||||
Transport Instructions |
Refrigerated |
||||||||||||
Specimen Stability |
Unacceptable Room Temperature |
||||||||||||
Methodology |
Quantitative Fluorometry |
||||||||||||
Days Performed |
TAT: 4-11 Days |
||||||||||||
Performing Laboratory |
ARUP Laboratories |
||||||||||||
CPT |
82657 |
||||||||||||
PDM |
225104 |
||||||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||||||
Results |
|
||||||||||||
Result Interpretation4.6 - 12.0 nmol hydrolyzed/hr/mg protein
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes. |
|||||||||||||
Forms |
|